News
LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% Ballerup, Denmark, 15 May, 2025 - In Q1, LEO Pharma continued its robust growth, driven by ...
Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback